Chang Zeng

980 total citations
19 papers, 312 citations indexed

About

Chang Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chang Zeng has authored 19 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Chang Zeng's work include Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (8 papers) and RNA modifications and cancer (6 papers). Chang Zeng is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (8 papers) and RNA modifications and cancer (6 papers). Chang Zeng collaborates with scholars based in United States, China and Canada. Chang Zeng's co-authors include Wei Zhang, Zhou Zhang, Brian C.‐H. Chiu, Emily K. Stroup, Chuan He, Shi‐Yuan Cheng, Bo Hu, Xiao Song, Craig Horbinski and Bingli Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Chang Zeng

19 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chang Zeng United States	10	221	156	54	33	28	19	312
Christina Alidousty Germany	12	209 0.9×	131 0.8×	116 2.1×	104 3.2×	30 1.1×	18	408
Eliza Wickham‐Garcia United States	6	176 0.8×	85 0.5×	49 0.9×	31 0.9×	36 1.3×	7	273
Jianghua Qiao China	12	155 0.7×	131 0.8×	120 2.2×	76 2.3×	26 0.9×	30	320
Xiuling Wu China	13	196 0.9×	125 0.8×	61 1.1×	100 3.0×	19 0.7×	31	347
Igor Makhlin United States	8	53 0.2×	51 0.3×	79 1.5×	73 2.2×	11 0.4×	18	247
Shigeki Tanishima Japan	10	58 0.3×	90 0.6×	87 1.6×	65 2.0×	50 1.8×	20	208
Shunro Uchinokura Japan	6	141 0.6×	36 0.2×	55 1.0×	18 0.5×	18 0.6×	8	300
Xiaomeng Hao China	8	229 1.0×	174 1.1×	165 3.1×	48 1.5×	9 0.3×	17	372
Shuqi Chi China	11	191 0.9×	101 0.6×	56 1.0×	33 1.0×	14 0.5×	19	346

Countries citing papers authored by Chang Zeng

Since Specialization

Citations

This map shows the geographic impact of Chang Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Zeng more than expected).

Fields of papers citing papers by Chang Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Zeng. The network helps show where Chang Zeng may publish in the future.

Co-authorship network of co-authors of Chang Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Zeng. A scholar is included among the top collaborators of Chang Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Zeng. Chang Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jin, Piaopiao, Yuping Liu, Zhimian Zhang, et al.. (2024). A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China. Nutrition Journal. 23(1). 64–64. 7 indexed citations

Zeng, Chang, Xiao Song, Zhou Zhang, et al.. (2023). Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis. Acta Neuropathologica Communications. 11(1). 133–133. 9 indexed citations

Zhang, Zhou, Xiaolong Cui, Chang Zeng, et al.. (2023). PETCH-DB: a Portal for Exploring Tissue-specific and Complex disease-associated 5-Hydroxymethylcytosines. Database. 2023. 4 indexed citations

Liu, Huanyu, Juanjuan Guo, Chang Zeng, et al.. (2022). Transient Early Fine Motor Abnormalities in Infants Born to COVID-19 Mothers Are Associated With Placental Hypoxia and Ischemia. Frontiers in Pediatrics. 9. 793561–793561. 14 indexed citations

Yang, Ying, Chang Zeng, Kun Yang, et al.. (2022). Genome-wide analysis reflects novel 5-hydroxymethylcytosines implicated in diabetic nephropathy and the biomarker potential. PubMed. 3(1). 49–60. 7 indexed citations

Zhang, Zhou, Chang Zeng, & Wei Zhang. (2022). Characterization of the Illumina EPIC array for optimal applications in epigenetic research targeting diverse human populations. SHILAP Revista de lepidopterología. 2(1). 1 indexed citations

Chiu, Brian C.‐H., Chang Chen, Qiancheng You, et al.. (2021). Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma. npj Genomic Medicine. 6(1). 11–11. 12 indexed citations

Chen, Chang, et al.. (2021). Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis. Frontiers in Oncology. 11. 620912–620912. 18 indexed citations

Cai, Jiajun, Chang Zeng, Wei Hua, et al.. (2021). An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas. Neuro-Oncology Advances. 3(1). vdab049–vdab049. 18 indexed citations

10.

Zhang, Zhou, Wenju Chang, Jiabin Cai, et al.. (2021). Multi-cancer detection and tissue of origin determination based on 5-hydroxymethylcytosine biomarkers in circulating cell-free DNA.. Journal of Clinical Oncology. 39(15_suppl). 3123–3123. 1 indexed citations

11.

Chiu, Brian C.‐H., Zhou Zhang, Benjamin A. Derman, et al.. (2021). 5-Hydroxymethylcytosines in circulating cell-free DNA and overall survival in patients with multiple myeloma.. Journal of Clinical Oncology. 39(15_suppl). 8032–8032. 1 indexed citations

12.

Han, Liyuan, Chang Chen, Xingyu Lu, et al.. (2020). Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes. Genomics. 113(1). 79–87. 8 indexed citations

13.

Ban, Yanli, Kruti P. Maniar, Haiyang Guo, et al.. (2020). Whole-Genome Sequencing and Target Validation Analysis of Müllerian Adenosarcoma: A Tumor With Complex but Specific Genetic Alterations. Frontiers in Oncology. 10. 538–538. 9 indexed citations

14.

Chiu, Brian C.‐H., Zhou Zhang, Jason Karpus, et al.. (2020). Abstract PR03: Genome-wide 5-hydroxymethylcytosine profiles in circulating cell-free DNA and survival in patients with multiple myeloma. Clinical Cancer Research. 26(11_Supplement). PR03–PR03. 1 indexed citations

15.

Song, Xiao, Xuechao Wan, Tianzhi Huang, et al.. (2019). SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes. Cancer Research. 79(20). 5288–5301. 73 indexed citations

16.

Zeng, Chang, Zhou Zhang, Jun Wang, et al.. (2019). Application of the High-Throughput TAB-Array for the Discovery of Novel 5-Hydroxymethylcytosine Biomarkers in Pancreatic Ductal Adenocarcinoma. Epigenomes. 3(3). 16–16. 5 indexed citations

17.

Yang, Ying, Chang Zeng, Xingyu Lu, et al.. (2019). 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes. Clinical Chemistry. 65(11). 1414–1425. 27 indexed citations

18.

Chiu, Brian C.‐H., Zhou Zhang, Qiancheng You, et al.. (2019). Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma. Blood Advances. 3(19). 2790–2799. 37 indexed citations

19.

Zeng, Chang, Emily K. Stroup, Zhou Zhang, Brian C.‐H. Chiu, & Wei Zhang. (2019). Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Communications. 39(1). 12–12. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact